Patents Assigned to Omrix Biopharmaceuticals SA
  • Patent number: 6916911
    Abstract: Use of fibrinogen multimers having at least 6 fibrinogen units as an ingredient for a fibrin sealant.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: July 12, 2005
    Assignee: OMRIX Biopharmaceuticals SA
    Inventors: Lily Bar, Israel Nur
  • Patent number: 6565539
    Abstract: The device for applying a flowable medium, in particular a tissue adhesive is provided with at least one reservoir (16) for the medium, wherein said reservoir (16) comprises an outlet (22) from which the medium exits when pressure is applied to the medium and/or said reservoir (16). A pressure-generating element (20) acts upon the medium and/or said reservoir (16) and is biased by a biasing means (34). Said biasing means (34) can be locked with the aid of a controllable locking means (58), wherein said locking means (58) comprises a movable fixing element (54) which, in at least one fixing position, locks the biasing element (34) against movements caused by the biasing process, and is movable out of the at least one fixing position to release said biasing element (34).
    Type: Grant
    Filed: February 12, 2002
    Date of Patent: May 20, 2003
    Assignee: OMRIX Biopharmaceuticals SA
    Inventors: Freddy Zinger, Igor Denenburg, Benny Kutal
  • Patent number: 6464663
    Abstract: The applicator (10) for depositing a one- or multi-component fluid, particularly a tissue adhesive, comprises a housing (12) arranged for attachment of at least one supply container (16) for the fluid. The supply container (16) comprises a discharge opening (28) and a piston (20) for sliding displacement in the direction of said discharge opening (28). A tensioning lever (58) is pivotally supported on the housing (12), which, when manually operated, causes movement of a spring tensioning element (54) by which a spring (46) for storage of mechanical energy can be tensioned. Coupled to the spring tensioning element (54) is a drive element (66) being adapted to be driven, by the stored mechanical energy of said spring (46), in increments and which is arranged to move a press-on element (84) acting on said piston (20) for displacing it in the direction of said discharge opening (28) of said supply container (16).
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: October 15, 2002
    Assignee: OMRIX Biopharmaceuticals SA
    Inventor: Freddy Zinger
  • Patent number: 6234994
    Abstract: An application device for applying a multicomponent tissue adhesive which includes a plurality of supply reservoirs for respectively one fluid component, each supply reservoir having a front end with an opening for discharge of the respective fluid component. The front ends of the supply reservoirs are arranged within accommodating connecting pieces of a connecting headpiece. The accommodating connecting pieces are provided with projections extending radially outwards. The supply reservoirs are held by a holding device. The application device is further provided with a coupling element for releasably connecting the holding device to the connecting headpiece, the coupling element including an encompassing member with a plurality of encompassing zones for at least partially encompassing the accommodating connecting pieces and for abutment on the sides of the projections of the accommodating connecting pieces facing away from the holding device.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: May 22, 2001
    Assignee: Omrix Biopharmaceuticals SA
    Inventor: Freddy Zinger
  • Patent number: 6121232
    Abstract: A stabilized solution of fibrinogen containing samples, in particular a stabilized solution of the biological active component (BAC) which is a solution of proteins derived from blood plasma comprising fibrinogen, tranexamic acid and arginine or lysine or mixtures or arginine and lysine, their pharmaceutically acceptable salts, as well as, optionally, substances forming a buffered solution in aqueous medium.
    Type: Grant
    Filed: February 10, 1997
    Date of Patent: September 19, 2000
    Assignee: Omrix Biopharmaceuticals SA
    Inventors: Israel Nur, Lilliana Bar, Oded Lieberman